$EVCM

EverCommerce Inc. (EVCM): Results of Operations and Financial Condition

EverCommerce Inc. (EVCM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 5 evcmq226earningsrelease.htm EX-99.1 Document Exhibit 99.1 EverCommerce Announces Second Quarter 2026 Financial Results Denver, CO ( August 5, 2026 ) EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading service commerce platform, today announced

Original reporting
Published Aug 5, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$EVCM
Neutral
medium confidence
Mentioned
$EVCM
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$EVCMNeutralMed
01

Why it matters

Traders can update models using the disclosed revenue and Adjusted EBITDA ranges and the company’s statement that full-year results are expected toward the lower end of guidance.

02

Market read

Fresh earnings and guidance ranges plus a qualitative shift to the low end of FY guidance are the primary drivers for near-term trading decisions.

03

What to watch

Adjusted EBITDA was slightly below prior-year level (44.5M vs 45.0M), so the key debate is whether margin pressure is temporary or structural, which the filing does not quantify.

Relevance 7/10Novelty 8/10Timing: pre-market positioning for the Aug 5, 2026 5:00 p.m. ET earnings call

Background

This is an SEC Form 8-K with Exhibit 99.1 covering EverCommerce’s Q2 2026 results and updated guidance for Q3 and full-year 2026.

Company-level read

Ticker impact

$EVCMNeutralMedium confidence
Context

EverCommerce reported Q2 2026 revenue of $152.0M and issued Q3 and full-year 2026 guidance, expecting full-year results toward the low end.

Expected impact

Likely choppy-to-soft reaction unless investors focus on in-line revenue and EBITDA range adherence; watch for follow-through after the 5:00 p.m. ET call.

Evidence & confidence

The filing discloses fresh, decision-relevant numbers: Q2 results plus explicit Q3 and FY 2026 revenue and Adjusted EBITDA ranges, and a qualitative shift to the lower end of guidance.

Market effects

Adds datapoint on service-commerce software demand and profitability trajectory for SMB-focused platforms.

No clear regional spillover indicated in the filing.

Limited global read-through beyond the company’s own guidance and platform execution.

Counterpoint

Investors may treat the quarter as in-line with revenue guidance and focus on subscription and transaction fee growth plus continued buybacks, implying the “moderated outlook” is already priced.

Key entities

  • EverCommerce Inc.

    Service commerce platform reporting Q2 2026 results and issuing Q3 and FY 2026 guidance in an 8-K.

  • Eric Remer

    Founder and CEO quoted on Q2 performance and moderated outlook.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.